Description
Specifications Table
Product Name – Human Recombinant Leukemia Inhibitory Factor (LIF) | CF061-5MCG
Quantity/Pack Size – 5 mcg
Form – Lyophilized powder
Grade – Research Grade
Application – Cell culture, stem cell research
Product Overview
Human Recombinant Leukemia Inhibitory Factor (LIF) is a high-quality protein essential for various research applications. This product is designed to support cell culture and stem cell research, providing a reliable and effective solution for scientists and researchers. The LIF protein is produced using advanced recombinant technology, ensuring high purity and consistency. It is ideal for use in laboratory settings where precision and reliability are paramount. The product is supplied in a lyophilized form, making it easy to store and handle. Its research-grade quality guarantees that it meets the stringent standards required for scientific investigations. Whether you are conducting basic research or advanced studies, this LIF protein is a valuable addition to your lab supplies.
FAQs
1. What is the primary application of Human Recombinant LIF?
Human Recombinant LIF is primarily used in cell culture and stem cell research to support the growth and maintenance of stem cells.
2. Is this product compatible with all types of cell cultures?
Yes, Human Recombinant LIF is compatible with a wide range of cell cultures, including embryonic stem cells and induced pluripotent stem cells.
3. Are there any alternatives to Human Recombinant LIF?
While Human Recombinant LIF is highly effective, other growth factors and cytokines can sometimes be used as alternatives depending on the specific research requirements.
4. How should Human Recombinant LIF be stored?
Human Recombinant LIF should be stored at -20°C or lower. Avoid repeated freeze-thaw cycles to maintain its stability and effectiveness.
5. Where can I source high-quality Human Recombinant LIF?
You can source high-quality Human Recombinant LIF from eqipped, a trusted provider of lab supplies for researchers and educators in India.
